Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
- Liposomal delivery
The in vitro / in vivo results proved that oligomeric DOCA improved cellular permeability and oral bioavailability
The G-BA's benefit assessment for the weight-management indication has proceeded under AMNOG, but reimbursement for obesity without comorbid T2D has not been broadly available under GKV as of mid-2026
Greater Phillys largest health insurer to restrict coverage for weight loss medications, citing exorbitant costs Independence Blue Cross joins other insurance companies in restricting coverage of Wegovy and Ozempic to Type 2 diabetes and heart disease
US$ 23.93
US$ 24.86
US$ 22.92
